معرفی
Frank Hernandez is an **Associate Professor and Docent** at **Linköping University**, leading the **Nucleic Acids Technologies Lab (NAT-Lab)** within the **Department of Physics, Chemistry and Biology (IFM)**. He holds a B.Sc. in Microbiology from the University of Antioquia (Colombia) and a PhD in Bioengineering from the University Rovira i Virgili (Spain). His research focuses on nucleic acid-based technologies for diagnostics and therapeutics, including drug delivery systems, nuclease biomarkers, and activatable probes for clinical applications.
- Educations:
- B.Sc. Microbiology, University of Antioquia (2003)
- PhD in Bioengineering, URV (2008)
Research Interests:
His work explores nucleic acids as biorecognition molecules for disease detection and therapy. Key areas include:
- Development of nuclease-activated diagnostic tools
- Targeted drug delivery using nanocarriers (e.g., TOUCAN platform)
- Biomarkers for cancer and bacterial infections
- Translation of nucleic acid technologies to clinical use
Grants & Recognition:
- **VR Grant (2025)** from the Swedish Research Council for precision antibiotics development
- Co-founder of a startup leveraging activatable probes for pathogen detection
Labs/Teams:
The NAT-Lab collaborates with the **Wallenberg Centre for Molecular Medicine (WCMM)** and focuses on interdisciplinary projects combining nanotechnology, molecular biology, and clinical translation.
